TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

NCT01328574 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

NIH

Sponsor class

Conditions

Urothelial Carcinoma
Ureteral Neoplasms
Ureter Cancer
Neoplasm, Ureteral
Cancer of the Ureter

Interventions

DRUG: TRC105

Sponsor

National Cancer Institute (NCI)